Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.
M F Linton, … , M R Wardell, S G Young
M F Linton, … , M R Wardell, S G Young
Published July 1, 1991
Citation Information: J Clin Invest. 1991;88(1):270-281. https://doi.org/10.1172/JCI115288.
View: Text | PDF
Research Article Article has an altmetric score of 6

Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.

  • Text
  • PDF
Abstract

Apolipoprotein (apo) E and the two B apolipoproteins, apoB48 and apoB100, are important proteins in human lipoprotein metabolism. Commonly occurring polymorphisms in the genes for apoE and apoB result in amino acid substitutions that produce readily detectable phenotypic differences in these proteins. We studied changes in apoE and apoB phenotypes before and after liver transplantation to gain new insights into apolipoprotein physiology. In all 29 patients that we studied, the postoperative serum apoE phenotype of the recipient, as assessed by isoelectric focusing, converted virtually completely to that of the donor, providing evidence that greater than 90% of the apoE in the plasma is synthesized by the liver. In contrast, the cerebrospinal fluid apoE phenotype did not change to the donor's phenotype after liver transplantation, indicating that most of the apoE in CSF cannot be derived from the plasma pool and therefore must be synthesized locally. The apoB100 phenotype (assessed with immunoassays using monoclonal antibody MB19, an antibody that detects a two-allele polymorphism in apoB) invariably converted to the phenotype of the donor. In four normolipidemic patients, we determined the MB19 phenotype of both the apoB100 and apoB48 in the "chylomicron fraction" isolated from plasma 3 h after a fat-rich meal. Interestingly, the apoB100 in the chylomicron fraction invariably had the phenotype of the donor, indicating that the vast majority of the large, triglyceride-rich apoB100-containing lipoproteins that appear in the plasma after a fat-rich meal are actually VLDL of hepatic origin. The MB19 phenotype of the apoB48 in the plasma chylomicron fraction did not change after liver transplantation, indicating that almost all of the apoB48 in plasma chylomicrons is derived from the intestine. These results were consistent with our immunocytochemical studies on intestinal biopsy specimens of organ donors; using apoB-specific monoclonal antibodies, we found evidence for apoB48, but not apoB100, in donor intestinal biopsy specimens.

Authors

M F Linton, R Gish, S T Hubl, E Bütler, C Esquivel, W I Bry, J K Boyles, M R Wardell, S G Young

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1986 Total
Citations: 3 9 14 17 11 16 9 5 7 9 10 12 10 8 11 12 8 4 5 5 5 9 10 8 10 10 13 12 6 4 7 2 4 3 2 290
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (290)

Title and authors Publication Year
Association between apolipoprotein E ε4 status and the risk of Alzheimer’s disease: a meta-analysis
Ren Z, Guan Z, Guan Q, Guan H, Guan H
BMC Neuroscience 2025
The Cross-Talk Between the Peripheral and Brain Cholesterol Metabolisms
Savulescu-Fiedler I, Dorobantu-Lungu LR, Dragosloveanu S, Benea SN, Dragosloveanu CD, Caruntu A, Scheau AE, Caruntu C, Scheau C
Current Issues in Molecular Biology 2025
HDL-replacement therapy: From traditional to emerging clinical applications
Sirtori CR, Cincotto G, Castiglione S, Pavanello C
Atherosclerosis Plus 2025
APOE genotype dictates lipidomic signatures in primary human hepatocytes.
Almeida FC, Patra K, Giannisis A, Niesnerova A, Nandakumar R, Ellis E, Oliveira TG, Nielsen HM
Journal of lipid research 2024
Insights into the roles of Apolipoprotein E in adipocyte biology and obesity.
Jiang CL, Lin FJ
International Journal of Obesity 2024
Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia
McInvale JJ, Canoll P, Hargus G
Brain Pathology 2024
Effect of Apolipoprotein E isoforms on the Abundance and Function of P-glycoprotein in Human Brain Microvascular Endothelial Cells
Kreutzer E, Short JL, Nicolazzo JA
Pharmaceutical Research 2024
Multifaceted roles of APOE in Alzheimer disease.
Jackson RJ, Hyman BT, Serrano-Pozo A
Nature reviews. Neurology 2024
Lipoprotein Particles in Cerebrospinal Fluid
Tsujita M, Melchior JT, Yokoyama S
Arteriosclerosis, thrombosis, and vascular biology 2024
Body Composition and Alzheimer’s Disease: A Holistic Review
Frank G, Gualtieri P, Cianci R, Caldarelli M, Palma R, De Santis GL, Porfilio C, Nicoletti F, Bigioni G, Di Renzo L
International Journal of Molecular Sciences 2024
Pathways to Alzheimer's Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health.
Laslo A, Laslo L, Arbănași EM, Ujlaki-Nagi AA, Chinezu L, Ivănescu AD, Arbănași EM, Cărare RO, Cordoș BA, Popa IA, Brînzaniuc K
Pathophysiology : the official journal of the International Society for Pathophysiology 2024
Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway.
Narasimhan S, Holtzman DM, Apostolova LG, Cruchaga C, Masters CL, Hardy J, Villemagne VL, Bell J, Cho M, Hampel H
Nature neuroscience 2024
Behavioral and cognitive performance of humanized APOEε3/ε3 liver mice in relation to plasma apolipoprotein E levels.
Kessler K, Giannisis A, Bial G, Foquet L, Nielsen HM, Raber J
Scientific Reports 2023
Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches.
Sun YY, Wang Z, Huang HC
Cellular and Molecular Neurobiology 2023
Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild cognitive impairment.
Giannisis A, Al-Grety A, Carlsson H, Howell JC, Hu WT, Kultima K, Nielsen HM
Alzheimer's research & therapy 2023
Apolipoprotein E in lipid metabolism and neurodegenerative disease.
Yang LG, March ZM, Stephenson RA, Narayan PS
Trends in endocrinology and metabolism: TEM 2023
ApoE expression in macrophages communicates immunometabolic signaling that controls hyperlipidemia-driven hematopoiesis & inflammation via extracellular vesicles.
Phu TA, Ng M, Vu NK, Gao AS, Raffai RL
Journal of Extracellular Vesicles 2023
ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury.
Laskowitz DT, Van Wyck DW
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023
Human cerebrospinal fluid contains diverse lipoprotein subspecies enriched in proteins implicated in central nervous system health
Merrill NJ, Davidson WS, He Y, Díaz Ludovico I, Sarkar S, Berger MR, McDermott JE, Van Eldik LJ, Wilcock DM, Monroe ME, Kyle JE, Bruce KD, Heinecke JW, Vaisar T, Raber J, Quinn JF, Melchior JT
Science Advances 2023
Alzheimer's Disease: Causal Effect between Obesity and APOE Gene Polymorphisms.
Zhao T, Zhong T, Zhang M, Xu Y, Zhang M, Chen L
International journal of molecular sciences 2023
Endothelial Cell APOE3 Regulates Neurovascular, Neuronal, and Behavioral Function
Marottoli FM, Zhang H, Flores-Barrera E, Artur de la Villarmois E, Damen FC, Miguelez Fernández AM, Blesson HV, Chaudhary R, Nguyen AL, Nwokeji AE, Talati R, John AS, Madadakere K, Lutz SE, Cai K, Tseng KY, Tai LM
Arteriosclerosis, thrombosis, and vascular biology 2023
Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia
Poliakova T, Wellington CL
Molecular Neurodegeneration 2023
Current Perspectives: Obesity and Neurodegeneration - Links and Risks
Kueck PJ, Morris JK, Stanford JA
Degenerative Neurological and Neuromuscular Disease 2023
APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread
Chen Y, Song S, Parhizkar S, Lord J, Zhu Y, Strickland MR, Wang C, Park J, Travis Tabor G, Jiang H, Li K, Davis AA, Yuede CM, Colonna M, Ulrich JD, Holtzman DM
Cell 2023
Brain apolipoprotein E levels in mice challenged by a Western diet increase in an allele-dependent manner.
Liemisa B, Newbury SF, Novy MJ, Pasato JA, Morales-Corraliza J, Peng KY, Mathews PM
2023
Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models
Matsuo K, Nshihara H
Neural Regeneration Research 2023
Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?
F Vecchio, P Bisceglia, B Imbimbo, M Lozupone, R Latino, E Resta, M Leone, V Solfrizzi, A Greco, A Daniele, M Watling, F Panza, D Seripa
Therapeutic Advances in Chronic Disease 2022
Insulin Resistance in Peripheral Tissues and the Brain: A Tale of Two Sites
Rhea EM, Banks WA, Raber J
Biomedicines 2022
APOE mediated neuroinflammation and neurodegeneration in Alzheimer’s Disease
Parhizkar S, Holtzman DM
Seminars in Immunology 2022
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.
Fernández-Calle R, Konings SC, Frontiñán-Rubio J, García-Revilla J, Camprubí-Ferrer L, Svensson M, Martinson I, Boza-Serrano A, Venero JL, Nielsen HM, Gouras GK, Deierborg T
Molecular Neurodegeneration 2022
APOE4 derived from astrocytes leads to blood-brain barrier impairment.
Jackson RJ, Meltzer JC, Nguyen H, Commins C, Bennett RE, Hudry E, Hyman BT
Brain : a journal of neurology 2022
Brain integrity is altered by hepatic APOE ε4 in humanized-liver mice.
Giannisis A, Patra K, Edlund AK, Nieto LA, Benedicto-Gras J, Moussaud S, de la Rosa A, Twohig D, Bengtsson T, Fu Y, Bu G, Bial G, Foquet L, Hammarstedt C, Strom S, Kannisto K, Raber J, Ellis E, Nielsen HM
Molecular Psychiatry 2022
Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function.
Liu CC, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, Doss SV, Shue F, Jeevaratnam S, Bastea L, Wang N, Martens YA, Qiao W, Wang M, Zhao N, Jia L, Yamazaki Y, Yamazaki A, Rosenberg CL, Wang Z, Kong D, Li Z, Kuchenbecker LA, Trottier ZA, Felton L, Rogers J, Quicksall ZS, Linares C, Knight J, Chen Y, Kurti A, Kanekiyo T, Fryer JD, Asmann YW, Storz P, Wang X, Peng J, Zhang B, Kim BYS, Bu G
Nature Neuroscience 2022
Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.
Giannisis A, Al-Grety A, Carlsson H, Patra K, Twohig D, Sando SB, Lauridsen C, Berge G, Grøntvedt GR, Bråthen G, White LR, Kultima K, Nielsen HM
Alzheimer's research & therapy 2022
Convergent cerebrospinal fluid proteomes and metabolic ontologies in humans and animal models of Rett syndrome.
Zlatic SA, Duong D, Gadalla KKE, Murage B, Ping L, Shah R, Fink JJ, Khwaja O, Swanson LC, Sahin M, Rayaprolu S, Kumar P, Rangaraju S, Bird A, Tarquinio D, Carpenter R, Cobb S, Faundez V
iScience 2022
Liver-ing in your head rent free: peripheral ApoE4 drives CNS pathology.
Golden LR, Johnson LA
Molecular Neurodegeneration 2022
Prophylactic treatment with CN-105 improves functional outcomes in a murine model of closed head injury.
Van Wyck D, Kolls BJ, Wang H, Cantillana V, Maughan M, Laskowitz DT
Experimental Brain Research 2022
Lipoproteins in the Central Nervous System: From Biology to Pathobiology.
Raulin AC, Martens YA, Bu G
Annual Review of Biochemistry 2022
ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies.
Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC
Molecular Neurodegeneration 2022
Exploring the Role of Lipid-Binding Proteins and Oxidative Stress in Neurodegenerative Disorders: A Focus on the Neuroprotective Effects of Nutraceutical Supplementation and Physical Exercise
Scarfò G, Piccarducci R, Daniele S, Franzoni F, Martini C
Antioxidants 2022
Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
Brodeur MR, Rhainds D, Charpentier D, Boulé M, Mihalache-Avram T, Mecteau M, Brand G, Pedneault-Gagnon V, Fortier A, Niesor EJ, Rhéaume E, Maugeais C, Tardif JC
Journal of lipid research 2022
Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementias.
Cooper O, Hallett P, Isacson O
The FEBS journal 2022
The small HDL particle hypothesis of Alzheimer’s disease
Martinez AE, Weissberger G, Kuklenyik Z, He X, Meuret C, Parekh T, Rees JC, Parks BA, Gardner MS, King SM, Collier TS, Harrington MG, Sweeney MD, Wang X, Zlokovic BV, Joe E, Nation DA, Schneider LS, Chui HC, Barr JR, Han SD, Krauss RM, Yassine HN
Alzheimer's & dementia : the journal of the Alzheimer's Association 2022
Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases
JV Valkenburgh, C Meuret, AE Martinez, V Kodancha, V Solomon, K Chen, HN Yassine
Frontiers in physiology 2021
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches
A Serrano-Pozo, S Das, BT Hyman
Lancet neurology 2021
The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer’s Disease: Exploring Interactions With Sex
Y Liu, JH Song, W Xu, XH Hou, JQ Li, JT Yu, L Tan, S Chi
Frontiers in neuroscience 2021
APOE signaling in neurodegenerative diseases: an integrative approach targeting APOE coding and noncoding variants for disease intervention
X Zhou, AK Fu, NY Ip
Current Opinion in Neurobiology 2021
Apolipoprotein E derived from CD11c+ cells ameliorates atherosclerosis
Sauter M, Sauter RJ, Nording H, Lin C, Olbrich M, Autenrieth S, Gleissner C, Thunemann M, Otero N, Lutgens E, Aherrahrou Z, Wolf D, Zender L, Meuth S, Feil R, Langer HF
iScience 2021
The Role of ApoE Expression and Variability of Its Glycosylation in Human Reproductive Health in the Light of Current Information
M Kacperczyk, A Kmieciak, EM Kratz
International journal of molecular sciences 2021
Interactions of Lipids, Lipoproteins, and Apolipoproteins with the Blood-Brain Barrier
EM Rhea, WA Banks
Pharmaceutical Research 2021
Dysregulation of Neuronal Nicotinic Acetylcholine Receptor–Cholesterol Crosstalk in Autism Spectrum Disorder
AS Vallés, FJ Barrantes
Frontiers in molecular neuroscience 2021
Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers
AK Edlund, K Chen, W Lee, H Protas, Y Su, E Reiman, R Caselli, HM Nielsen
Journal of Alzheimer's disease : JAD 2021
Is pseudoexfoliation glaucoma a neurodegenerative disorder?
B Padhy, DP Alone
Journal of Biosciences 2021
Hypothesis: Entrapment of lipoprotein particles in the brain causes Alzheimer's disease.
Boche D, Nicoll JA
Free neuropathology 2021
ApoE mimetic improves pathology and memory in a model of Alzheimer’s disease
K Krishnamurthy, V Cantillana, H Wang, PM Sullivan, BJ Kolls, X Ge, Y Lin, B Mace, DT Laskowitz
Brain Research 2020
Apolipoprotein E Signals via TLR4 to Induce CXCL5 Secretion by Asthmatic Airway Epithelial Cells
O Kalchiem-Dekel, X Yao, AV Barochia, M Kaler, DM Figueroa, WB Karkowsky, EM Gordon, M Gao, MM Fergusson, X Qu, P Liu, Y Li, F Seifuddin, M Pirooznia, SJ Levine
American journal of respiratory cell and molecular biology 2020
APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Z Li, F Shue, N Zhao, M Shinohara, G Bu
Molecular Neurodegeneration 2020
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
T Williams, DR Borchelt, P Chakrabarty
Molecular Neurodegeneration 2020
Transendothelial transport of lipoproteins
E Jang, J Robert, L Rohrer, A von Eckardstein, WL Lee
Atherosclerosis 2020
Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review
JC Nascimento, GA Matos, LC Pereira, AE Mourão, AM Sampaio, RB Oriá, P Toniutto
ANN HEPATOL 2020
The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
D Chernick, R Zhong, L Li
Biomolecules 2020
Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia
M Koch, ST DeKosky, M Goodman, J Sun, JD Furtado, AL Fitzpatrick, RH Mackey, T Cai, OL Lopez, LH Kuller, KJ Mukamal, MK Jensen
2020
Sphingolipids in Alzheimer's disease, how can we target them?
SM Crivelli, C Giovagnoni, L Visseren, AL Scheithauer, N de Wit, S den Hoedt, M Losen, MT Mulder, J Walter, HE de Vries, E Bieberich, P Martinez-Martinez
Advanced Drug Delivery Reviews 2020
Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E
J Robert, EB Button, EM Martin, L McAlary, Z Gidden, M Gilmour, G Boyce, TM Caffrey, A Agbay, A Clark, JM Silverman, NR Cashman, CL Wellington
Molecular Neurodegeneration 2020
Pulsed SILAM Reveals In Vivo Dynamics of Murine Brain Protein Translation
SS Ng, JE Park, W Meng, CP Chen, RN Kalaria, NE McCarthy, SK Sze
ACS Omega 2020
Beyond the CNS: The many peripheral roles of APOE
AB Martinez-Martínez, E Torres-Perez, N Devanney, RD Moral, LA Johnson, JM Arbones-Mainar
Neurobiology of Disease 2020
Therapeutic Development of Apolipoprotein E Mimetics for Acute Brain Injury: Augmenting Endogenous Responses to Reduce Secondary Injury
ML James, JM Komisarow, H Wang, DT Laskowitz
Neurotherapeutics 2020
An in vitro bioengineered model of the human arterial neurovascular unit to study neurodegenerative diseases
J Robert, NL Weilinger, LP Cao, S Cataldi, EB Button, S Stukas, EM Martin, P Seibler, M Gilmour, TM Caffrey, EM Rowe, J Fan, B MacVicar, MJ Farrer, CL Wellington
Molecular Neurodegeneration 2020
Validation of a novel and accurate ApoE4 assay for automated chemistry analyzers
S Veiga, A Rodríguez-Martín, G Garcia-Ribas, I Arribas, M Menacho-Román, M Calero
Scientific Reports 2020
High‐density lipoprotein‐related cholesterol metabolism in Alzheimer’s disease
S Pedrini, P Chatterjee, E Hone, RN Martins
Journal of Neurochemistry 2020
Tau Biology
A Takashima, B Wolozin, L Buee
2019
Tau Biology
A Takashima, B Wolozin, L Buee
2019
Peripheral versus central nervous system APOE in Alzheimer’s disease: Interplay across the blood-brain barrier
D Chernick, S Ortiz-Valle, A Jeong, W Qu, L Li
Neuroscience Letters 2019
Cholesterol Metabolism in the Brain and Its Association with Parkinson’s Disease
U Jin, SJ Park, SM Park
Experimental Neurobiology 2019
Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort
KL Rasmussen, A Tybjærg-Hansen, BG Nordestgaard, R Frikke-Schmidt
European Heart Journal 2019
A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
ME Belloy, V Napolioni, MD Greicius
Neuron 2019
Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells
CS Baaklini, KS Rawji, GJ Duncan, MF Ho, JR Plemel
Frontiers in molecular neuroscience 2019
Neurodegeneration and Alzheimer's Disease: The Role of Diabetes, Genetics, Hormones, and Lifestyle
RN Martins, CS Brennan, WM Fernando, MA Brennan, SJ Fuller
2019
Lipid-Binding Proteins in Brain Health and Disease
M Corraliza-Gomez, D Sanchez, MD Ganfornina
Frontiers in neurology 2019
Site-specific effects of apolipoprotein E expression on diet-induced obesity and white adipose tissue metabolic activation
A Hatziri, C Kalogeropoulou, E Xepapadaki, E Birli, EA Karavia, E Papakosta, S Filou, C Constantinou, KE Kypreos
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018
Apolipoproteins and Alzheimer's pathophysiology
M Koch, ST DeKosky, AL Fitzpatrick, JD Furtado, OL Lopez, LH Kuller, RH Mackey, TM Hughes, KJ Mukamal, MK Jensen
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2018
Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury
X Cheng, Y Zheng, P Bu, X Qi, C Fan, F Li, DH Kim, Q Cao
Experimental Neurology 2018
Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals
KL Rasmussen, A Tybjærg-Hansen, BG Nordestgaard, R Frikke-Schmidt
Alzheimer's & dementia : the journal of the Alzheimer's Association 2018
High-Density Lipoprotein Subclasses and Mild Cognitive Impairment: Study of Outcome and aPolipoproteins in Dementia (STOP-Dementia) 1
R Ohtani, S Nirengi, M Nakamura, N Murase, M Sainouchi, Y Kuwata, M Takata, Y Masuda, K Kotani, N Sakane
Journal of Alzheimer's disease : JAD 2018
Apolipoprotein E, Receptors and Modulation of Alzheimer’s Disease
N Zhao, CC Liu, W Qiao, G Bu
Biological Psychiatry 2017
Endothelial LRP1 – A Potential Target for the Treatment of Alzheimer’s Disease: Theme: Drug Discovery, Development and Delivery in Alzheimer’s Disease Guest Editor: Davide Brambilla
SE Storck, CU Pietrzik
Pharmaceutical Research 2017
Lipid Processing in the Brain: A Key Regulator of Systemic Metabolism
KD Bruce, A Zsombok, RH Eckel
Frontiers in Endocrinology 2017
Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perception
Kyriakos E Kypreos, Eleni A Karavia, Caterina Constantinou, Aikaterini Hatziri, Christina Kalogeropoulou, Eva Xepapadaki, Evangelia Zvintzou
Journal of Biomedical Research 2017
Neuroprotective pentapeptide CN-105 is associated with reduced sterile inflammation and improved functional outcomes in a traumatic brain injury murine model
DT Laskowitz, H Wang, T Chen, DT Lubkin, V Cantillana, TM Tu, D Kernagis, G Zhou, G Macy, BJ Kolls, HN Dawson
Scientific Reports 2017
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer’s Disease
P Johansson, EG Almqvist, M Bjerke, A Wallin, JO Johansson, U Andreasson, K Blennow, H Zetterberg, J Svensson
Journal of Alzheimer's disease : JAD 2017
Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma
M Koch, JD Furtado, K Falk, F Leypoldt, KJ Mukamal, MK Jensen
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2017
Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma
AT Baker-Nigh, KG Mawuenyega, JG Bollinger, V Ovod, T Kasten, EE Franklin, F Liao, H Jiang, D Holtzman, NJ Cairns, JC Morris, RJ Bateman
The Journal of biological chemistry 2016
Central Nervous System LipoproteinsHighlights: ApoE and Regulation of Cholesterol Metabolism
RW Mahley
Arteriosclerosis, thrombosis, and vascular biology 2016
Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
RW Mahley
Journal of Molecular Medicine 2016
Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation
TM Achariyar, B Li, W Peng, PB Verghese, Y Shi, E McConnell, A Benraiss, T Kasper, W Song, T Takano, DM Holtzman, M Nedergaard, R Deane
Molecular Neurodegeneration 2016
Plasma apolipoprotein E and severity of suicidal behaviour
P Asellus, P Nordström, AL Nordström, J Jokinen
Journal of Affective Disorders 2016
Developing Therapeutics for Alzheimer's Disease
H Zetterberg, K Blennow
Developing Therapeutics for Alzheimer's Disease 2016
Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review
KL Rasmussen
Atherosclerosis 2016
Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins
A Boehm-Cagan, R Bar, D Harats, A Shaish, H Levkovitz, JK Bielicki, JO Johansson, DM Michaelson, MK Lakshmana
PloS one 2016
Advances in high-density lipoprotein physiology: surprises, overturns, and promises
C Constantinou, EA Karavia, E Xepapadaki, PI Petropoulou, E Papakosta, M Karavyraki, E Zvintzou, V Theodoropoulos, S Filou, A Hatziri, C Kalogeropoulou, G Panayiotakopoulos, KE Kypreos
American journal of physiology. Endocrinology and metabolism 2016
Plasma levels of apolipoprotein E and risk of dementia in the general population: Plasma apoE and Dementia
KL Rasmussen, A Tybjaerg-Hansen, BG Nordestgaard, R Frikke-Schmidt
Annals of Neurology 2015
Apolipoprotein E levels and Alzheimer risk: ApoE Levels and Alzheimer Risk
BT Hyman, DM Holtzman
Annals of Neurology 2015
APOE -modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data and future perspective
LM Tai, S Ghura, KP Koster, V Liakaite, M Maienschein-Cline, P Kanabar, N Collins, M Ben-Aissa, AZ Lei, N Bahroos, S Green, B Hendrickson, LJ van Eldik, MJ LaDu
Journal of Neurochemistry 2015
Cholesterol metabolism and homeostasis in the brain
J Zhang, Q Liu
Protein & Cell 2015
Biochemical properties in membrane of rat astrocytes under oxidative stress
J Ito, Y Nagayasu, T Ogawa, H Okihara, M Michikawa
Brain Research 2015
Cholesterol in myelin biogenesis and hypomyelinating disorders
G Saher, SK Stumpf
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2015
High-density lipoproteins at the interface between central nervous system and plasma lipoprotein metabolism
J Robert, WH Cheng, A Hayat, T Ward-Able, CL Wellington
Clinical Lipidology 2015
Comparative Proteomic Analysis of Two Uveitis Models in Lewis Rats
KL Pepple, L Rotkis, L Wilson, A Sandt, RN van Gelder
Investigative ophthalmology & visual science 2015
Plasma biomarkers for neuronal ceroid lipofuscinosis
SL Hersrud, RD Geraets, KL Weber, CH Chan, DA Pearce
FEBS Journal 2015
Apolipoprotein Mimetics in the Management of Human Disease
GM Anantharamaiah, D Goldberg
2015
HDL and cognition in neurodegenerative disorders
DA Hottman, D Chernick, S Cheng, Z Wang, L Li
Neurobiology of Disease 2014
Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein E
M Lefèvre, DJ Felmlee, M Parnot, TF Baumert, C Schuster
PloS one 2014
ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro
E Nwabuisi‑Heath, GW Rebeck, MJ LaDu, C Yu
ASN NEURO 2014
ApoA-I/HDL Generation and Intracellular Cholesterol Transport through Cytosolic Lipid-Protein Particles in Astrocytes
J Ito, M Michikawa
Journal of Lipids 2014
Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice
H Tavori, D Fan, I Giunzioni, L Zhu, MF Linton, AB Fogo, S Fazio
Journal of lipid research 2014
Development and partial characterisation of an antiserum against apolipoprotein B of the short-finned eel, Anguilla australis
EL Damsteegt, H Mizuta, Y Ozaki, N Hiramatsu, T Todo, A Hara, S Ijiri, S Adachi, PM Lokman
Journal of Comparative Physiology B 2014
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls
E Martínez-Morillo, O Hansson, Y Atagi, G Bu, L Minthon, EP Diamandis, HM Nielsen
Acta Neuropathologica 2014
High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease
S Stukas, J Robert, CL Wellington
Cell Metabolism 2014
Increasing cellular level of phosphatidic acid enhances FGF-1 production in long term-cultured rat astrocytes
Y Nagayasu, S Morita, H Hayashi, Y Miura, K Yokoyama, M Michikawa, J Ito
Brain Research 2014
Astrocyte׳s endogenous apoE generates HDL-like lipoproteins using previously synthesized cholesterol through interaction with ABCA1
J Ito, Y Nagayasu, Y Miura, S Yokoyama, M Michikawa
Brain Research 2014
HDL and cholesterol handling in the brain
C Vitali, CL Wellington, L Calabresi
Cardiovascular Research 2014
Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein E
M Lefèvre, DJ Felmlee, M Parnot, TF Baumert, C Schuster, R Ray
PloS one 2014
Hormonal modulators of glial ABCA1 and apoE levels
J Fan, Y Shimizu, J Chan, A Wilkinson, A Ito, P Tontonoz, E Dullaghan, LA Galea, T Pfeifer, CL Wellington
Journal of lipid research 2013
Links between copper and cholesterol in Alzheimer's disease
YH Hung, AI Bush, SL Fontaine
Frontiers in physiology 2013
Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease
RE Kennedy, GR Cutter, LS Schneider
Alzheimer's and Dementia 2013
ApolipoproteinE mimetic peptides improve outcome after focal ischemia
H Wang, LG Anderson, CD Lascola, ML James, TN Venkatraman, ER Bennett, SK Acheson, MP Vitek, DT Laskowitz
Experimental Neurology 2013
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis
J Wei, M Zheng, P Liang, Y Wei, X Yin, Y Tang, Y Xue
Neurobiology of Disease 2013
Enhancement of FGF-1 release along with cytosolic proteins from rat astrocytes by hydrogen peroxide
J Ito, Y Nagayasu, M Hoshikawa, KH kato, Y Miura, K Asai, H Hayashi, S Yokoyama, M Michikawa
Brain Research 2013
Serum Apolipoprotein E as a Marker to Monitor Graft Function After Hepatocyte Transplantation in a Clinically Relevant Mouse Model
C Jorns, T Takahashi, E Callaghan, H Zemack, L Larsson, G Nowak, P Parini, BG Ericzon, E Ellis
Transplantation Proceedings 2013
ApoE and outcome after traumatic brain injury
S Gokhale, DT Laskowitz
Clinical Lipidology 2013
Apolipoprotein E Levels in the Cerebrospinal Fluid of North Indian Patients With Alzheimer’s Disease
RJ Kandimalla, WY Wani, R Anand, A Kaushal, S Prabhakar, VK Grover, N Bharadwaj, K Jain, KD Gill
American journal of Alzheimer's disease and other dementias 2013
Genetic Variants in Alzheimer's Disease
K Morgan, MM Carrasquillo
2013
Cholesterol: Its Regulation and Role in Central Nervous System Disorders
M Orth, S Bellosta
Cholesterol 2012
Potential biomarkers in psychiatry: focus on the cholesterol system
AG Woods, I Sokolowska, R Taurines, M Gerlach, E Dudley, J Thome, CC Darie
Journal of Cellular and Molecular Medicine 2012
In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
KR Wildsmith, JM Basak, BW Patterson, Y Pyatkivskyy, J Kim, KE Yarasheski, JX Wang, KG Mawuenyega, H Jiang, M Parsadanian, H Yoon, T Kasten, WC Sigurdson, C Xiong, A Goate, DM Holtzman, RJ Bateman
PloS one 2012
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
C Cruchaga, JS Kauwe, P Nowotny, K Bales, EH Pickering, K Mayo, S Bertelsen, A Hinrichs, AM Fagan, DM Holtzman, JC Morris, AM Goate
Human Molecular Genetics 2012
Administration of COG1410 Reduces Axonal Amyloid Precursor Protein Immunoreactivity and Microglial Activation after Controlled Cortical Impact in Mice
Y Jiang, DL Brody
Journal of Neurotrauma 2012
Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation
E Cudaback, X Li, Y Yang, T Yoo, KS Montine, S Craft, TJ Montine, CD Keene
Journal of Neuroinflammation 2012
In Vivo Human Apolipoprotein E Isoform Fractional Turnover Rates in the CNS
KR Wildsmith, JM Basak, BW Patterson, Y Pyatkivskyy, J Kim, KE Yarasheski, JX Wang, KG Mawuenyega, H Jiang, M Parsadanian, H Yoon, T Kasten, WC Sigurdson, C Xiong, A Goate, DM Holtzman, RJ Bateman, S Estus
PloS one 2012
Macrophage-Specific ApoE Gene Repair Reduces Diet-Induced Hyperlipidemia and Atherosclerosis in Hypomorphic Apoe Mice
N Gaudreault, N Kumar, VR Olivas, D Eberlé, JH Rapp, RL Raffai, M Lisanti
PloS one 2012
Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo
N Luo, X Wang, BH Chung, MH Lee, RL Klein, WT Garvey, Y Fu
American journal of physiology. Endocrinology and metabolism 2011
ApoA-I enhances generation of HDL-like lipoproteins through interaction between ABCA1 and phospholipase Cγ in rat astrocytes
J Ito, Y Nagayasu, A Kheirollah, S Abe-Dohmae, S Yokoyama
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2011
An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia
J Fan, S Stukas, C Wong, J Chan, S May, N DeValle, V Hirsch-Reinshagen, A Wilkinson, MN Oda, CL Wellington
Journal of lipid research 2011
Apolipoprotein E: from lipid transport to neurobiology
PS Hauser, V Narayanaswami, RO Ryan
Progress in Lipid Research 2011
Cholesterol metabolism in neurons and astrocytes
FW Pfrieger, N Ungerer
Progress in Lipid Research 2011
Lipid metabolism in the central nervous system and neurodegenerative diseases
H Hayashi
Folia Pharmacologica Japonica 2011
Lipid Metabolism and Glial Lipoproteins in the Central Nervous System
H Hayashi
Biological & Pharmaceutical Bulletin 2011
The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1
S Stukas, S May, A Wilkinson, J Chan, J Donkin, CL Wellington
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2011
An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia
J Fan, S Stukas, C Wong, J Chan, S May, N DeValle, V Hirsch-Reinshagen, A Wilkinson, MN Oda, CL Wellington
Journal of lipid research 2011
Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors
J Brodbeck, J McGuire, Z Liu, A Meyer-Franke, ME Balestra, D Jeong, M Pleiss, C McComas, F Hess, D Witter, S Peterson, M Childers, M Goulet, N Liverton, R Hargreaves, S Freedman, KH Weisgraber, RW Mahley, Y Huang
The Journal of biological chemistry 2011
Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo
N Luo, X Wang, BH Chung, MH Lee, RL Klein, WT Garvey, Y Fu
American journal of physiology. Endocrinology and metabolism 2011
Diet and Age Interactions with Regards to Cholesterol Regulation and Brain Pathogenesis
RM Uranga, JN Keller
Current Gerontology and Geriatrics Research 2010
Apolipoproteins in the brain: implications for neurological and psychiatric disorders
DA Elliott, CS Weickert, B Garner
Clinical Lipidology 2010
Traumatic Brain Injury Exacerbates Neurodegenerative Pathology: Improvement with an Apolipoprotein E-Based Therapeutic
DT Laskowitz, P Song, H Wang, B Mace, PM Sullivan, MP Vitek, HN Dawson
Journal of Neurotrauma 2010
The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis
H Zhang, J Wu, J Zhu
Journal of biomedicine & biotechnology 2010
The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis
HL Zhang, J Wu, J Zhu
Clinical & developmental immunology 2010
Comment on: Cerebrospinal fluid apolipoprotein E concentration decreases after seizure
J Wu, P Liu, J Lei, HL Zhang
Seizure 2010
Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: A nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid
P Khumsupan, R Ramirez, D Khumsupan, V Narayanaswami
Biochimica et Biophysica Acta 2010
COG1410, an Apolipoprotein E-based Peptide, Improves Cognitive Performance and Reduces Cortical Loss Following Moderate Fluid Percussion Injury in the Rat
NA Kaufman, JE Beare, AA Tan, MP Vitek, SE McKenna, MR Hoane
Behavioural Brain Research 2010
Lipoprotein remodelling in the periphery: A model for the brain?
C Yu, KL Youmans, MJ LaDu
Biochimica et Biophysica Acta 2010
Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease?
MR Farlow
Alzheimer's research & therapy 2010
Novel Genetic Mutation in Apolipoprotein E2 Homozygosis and Its Implication in Organ Donation: A Case Report
N Cautero, FD Benedetto, ND Ruvo, R Montalti, GP Guerrini, R Ballarin, M Spaggiari, N Smerieri, MG Blasiis, G Rompianesi, RM Iemmolo, M Marino, M Bertolotti, S Zivieri, GE Gerunda
Transplantation Proceedings 2010
Pyrene Fluorescence Analysis Offers New Insights into the Conformation of the Lipoprotein-Binding Domain of Human Apolipoprotein E
AB Patel, P Khumsupan, V Narayanaswami
Biochemistry 2010
Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo
ZH Huang, D Gu, T Mazzone
American journal of physiology. Endocrinology and metabolism 2009
APOEmRNA and protein expression in postmortem brain are modulated by an extended haplotype structure
LM Bekris, NM Galloway, TJ Montine, GD Schellenberg, CE Yu
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2009
COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia
EA Tukhovskaya, AY Yukin, ON Khokhlova, AN Murashev, MP Vitek
Journal of Neuroscience Research 2009
COG1410 Improves Cognitive Performance and Reduces Cortical Neuronal Loss in the Traumatically Injured Brain
MR Hoane, N Kaufman, MP Vitek, SE McKenna
Journal of Neurotrauma 2009
Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease
IJ Martins, T Berger, MJ Sharman, G Verdile, SJ Fuller, RN Martins
Journal of Neurochemistry 2009
Differential effects of simvastatin and pravastatin on expression of Alzheimer’s disease-related genes in human astrocytes and neuronal cells
W Dong, S Vuletic, JJ Albers
Journal of lipid research 2009
Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo
ZH Huang, DS Gu, T Mazzone
American journal of physiology. Endocrinology and metabolism 2009
Pharmacogenomic Effects of Apolipoprotein E on Intracerebral Hemorrhage
ML James, PM Sullivan, CD Lascola, MP Vitek, DT Laskowitz
Stroke; a journal of cerebral circulation 2009
Apolipoprotein E isoform-specific disruption of Alzheimer's amyloid beta-peptide clearance from brain
Rashid Deane, Abhay Sagare, Katie Hamm, Margaret Parisi, Steven Lane, Mary Beth Finn, David M. Holtzman, Berislav V. Zlokovic
Journal of Clinical Investigation 2008
Apolipoprotein E and cholesterol in aging and disease in the brain
EP de Chaves, V Narayanaswami
Future Lipidology 2008
Multiple SNPs Within and Surrounding the Apolipoprotein E Gene Influence Cerebrospinal Fluid Apolipoprotein E Protein Levels
LM Bekris, SP Millard, NM Galloway, S Vuletic, JJ Albers, G Li, DR Galasko, C DeCarli, MR Farlow, CM Clark, JF Quinn, JA Kaye, GD Schellenberg, D Tsuang, ER Peskind, CE Yu
Journal of Alzheimer's disease : JAD 2008
Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice
RD Atkinson, KR Coenen, MR Plummer, ML Gruen, AH Hasty
American journal of physiology. Endocrinology and metabolism 2008
Prevention of stroke and dementia by statin therapy: Experimental and clinical evidence of their pleiotropic effects
T Miida, A Takahashi, T Ikeuchi
Pharmacology & Therapeutics 2007
Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions
DT Laskowitz, MP Vitek
Pharmacogenomics 2007
An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer’s disease pathology following closed head injury: Evidence of pharmacogenomic interaction
H Wang, L Durham, H Dawson, P Song, DS Warner, PM Sullivan, MP Vitek, DT Laskowitz
Neuroscience 2007
COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury
DT Laskowitz, SE McKenna, P Song, H Wang, L Durham, N Yeung, D Christensen, MP Vitek
Journal of Neurotrauma 2007
Impaired Secretion of Apolipoprotein E2 from Macrophages
D Fan, S Qiu, CD Overton, PG Yancey, LL Swift, WG Jerome, MR Linton, S Fazio
The Journal of biological chemistry 2007
Assessment of Nutritional Status and Prediction of Postoperative Liver Function from Serum Apolioprotein A-1 Levels with Hepatectomy
T Katsuramaki, T Mizuguchi, M Kawamoto, K Yamaguchi, M Meguro, M Nagayama, T Nobuoka, Y Kimura, T Furuhata, K Hirata
World Journal of Surgery 2006
Genetic Factors in Outcome After Traumatic Brain Injury
R Diaz-Arrastia, VK Baxter
Journal of Head Trauma Rehabilitation 2006
Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function
M Michikawa
Acta Neurologica Scandinavica 2006
Apolipoprotein E-derived peptides reduce CNS inflammation: implications for therapy of neurological disease
DT Laskowitz, H Fillit, N Yeung, K Toku, MP Vitek
Acta Neurologica Scandinavica 2006
A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage
J Gao, H Wang, H Sheng, JR Lynch, DS Warner, L Durham, MP Vitek, DT Laskowitz
Neurocritical Care 2006
A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury
JR Lynch, H Wang, B Mace, S Leinenweber, DS Warner, ER Bennett, MP Vitek, S McKenna, DT Laskowitz
Experimental Neurology 2005
Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic–ischemic injury
J Mcadoo, D Warner, R Goldberg, M Vitek, R Pearlstein, D Laskowitz
Neuroscience Letters 2005
The Blood-Brain Barrier and Its Microenvironment: Basic Physiology to Neurological Disease
H Wolburg, A Warth
The Blood-Brain Barrier and Its Microenvironment: Basic Physiology to Neurological Disease 2005
Astrocytes produce and secrete FGF-1, which promotes the production of apoE-HDL in a manner of autocrine action
J Ito, Y Nagayasu, R Lu, A Kheirollah, M Hayashi, S Yokoyama
Journal of lipid research 2005
Generation and function of astroglial lipoproteins from Niemann–Pick type C1-deficient mice
B KARTEN, H HAYASHI, GA FRANCIS, RB CAMPENOT, DE VANCE, JE VANCE
Biochemical Journal 2005
Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta
M Morikawa, JD Fryer, PM Sullivan, EA Christopher, SE Wahrle, RB DeMattos, MA O'Dell, AM Fagan, HA Lashuel, T Walz, K Asai, DM Holtzman
Neurobiology of Disease 2004
A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes
Y Liang, S Lin, TP Beyer, Y Zhang, X Wu, KR Bales, RB DeMattos, PC May, SD Li, XC Jiang, PI Eacho, G Cao, SM Paul
Journal of Neurochemistry 2004
Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism
CL Wellington
Clinical Genetics 2004
Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity
I Maezawa, LW Jin, RL Woltjer, N Maeda, GM Martin, TJ Montine, KS Montine
Journal of Neurochemistry 2004
ApoAI Deficiency Results in Marked Reductions in Plasma Cholesterol But No Alterations in Amyloid-β Pathology in a Mouse Model of Alzheimer's Disease-Like Cerebral Amyloidosis
AM Fagan, E Christopher, JW Taylor, M Parsadanian, M Spinner, M Watson, JD Fryer, S Wahrle, KR Bales, SM Paul, DM Holtzman
The American Journal of Pathology 2004
ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
AM Fagan, E Christopher, JW Taylor, M Parsadanian, M Spinner, M Watson, JD Fryer, S Wahrle, KR Bales, SM Paul, DM Holtzman
The American Journal of Pathology 2004
Identification of a novel enhancer of brain expression near the apoE gene cluster by comparative genomics
Ping Zheng, Len A Pennacchio, Wilfried Le Goff, Edward M Rubin, Jonathan D Smith
Biochimica et Biophysica Acta 2004
Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain
V Hirsch-Reinshagen, S Zhou, BL Burgess, L Bernier, SA McIsaac, JY Chan, GH Tansley, JS Cohn, MR Hayden, CL Wellington
The Journal of biological chemistry 2004
ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE
SE Wahrle, H Jiang, M Parsadanian, J Legleiter, X Han, JD Fryer, T Kowalewski, DM Holtzman
The Journal of biological chemistry 2004
Levels of apolipoprotein A-II in cerebrospinal fluid in patients with neuroborreliosis are associated with lipophagocytosis
L Táborský, P Adam, O Sobek, M Dostál, J Dvořáková, L Dubská
Folia Microbiologica 2003
Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage
AD Kay, SP Day, JA Nicoll, CJ Packard, MJ Caslake
Atherosclerosis 2003
Lipoproteins produced by ApoE-/- astrocytes infected with adenovirus expressing human ApoE
D Peng, C Song, CA Reardon, S Liao, GS Getz
Journal of Neurochemistry 2003
Cerebrospinal Fluid Apolipoprotein E Concentration Decreases after Traumatic Brain Injury
AD Kay, A Petzold, M Kerr, G Keir, EJ Thompson, JA Nicoll
Journal of Neurotrauma 2003
Remodeling of Cerebrospinal Fluid Lipoprotein Particles after Human Traumatic Brain Injury
AD Kay, SP Day, M Kerr, JA Nicoll, CJ Packard, MJ Caslake
Journal of Neurotrauma 2003
Alzheimer’s Disease
DS Vohora, LC Mishra
Scientific Basis for Ayurvedic Therapies 2003
Widespread distribution of PLTP in human CNS: evidence for PLTP synthesis by glia and neurons, and increased levels in Alzheimer's disease
S Vuletic, LW Jin, SM Marcovina, ER Peskind, T Möller, JJ Albers
Journal of lipid research 2003
Cholesterol: from heart attacks to Alzheimer's disease
RL Raffaï, KH Weisgraber
Journal of lipid research 2003
APOE ε3/ε4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer’s disease diagnosis
H Fukumoto, M Ingelsson, N Gårevik, LO Wahlund, N Nukina, Y Yaguchi, M Shibata, BT Hyman, GW Rebeck, MC Irizarry
Experimental Neurology 2003
Differential metabolism of ApoE isoforms in plasma and CSF
SE Wahrle, DM Holtzman
Experimental Neurology 2003
Changes in serum levels of apolipoprotein A-1 as an indicator of protein metabolism after hepatectomy
T Katsuramaki, K Hirata, Y Kimura, M Nagayama, M Meguro, H Kimura, T Honma, T Furuhata, U Hideki, F Hata, M Mukaiya
Wound Repair and Regeneration 2002
Bone marrow chimerism prevents atherosclerosis in arterial walls of mice deficient in apolipoprotein E
Y Sakai, DK Kim, S Iwasa, J Liang, T Watanabe, M Onodera, H Nakauchi
Atherosclerosis 2002
Apolipoproteins and aging: emerging mechanisms
JD Smith
Ageing Research Reviews 2002
Apolipoproteins and ? Amyloid Transport Pathway
K Kamino, T Kida, T Tanaka, H Tanii, M Okochi, T Kudo, T Kobayashi, M Takeda
Psychogeriatrics 2002
Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes
K Bach-Ngohou, K Ouguerram, H Nazih, P Maugère, B Ripolles-Piquer, Y Zaïr, R Frénais, M Krempf, JM Bard
International Journal of Obesity 2002
Hypomorphic Apolipoprotein E Mice: A NEW MODEL OF CONDITIONAL GENE REPAIR TO EXAMINE APOLIPOPROTEIN E-MEDIATED METABOLISM
RL Raffaı̈, KH Weisgraber
The Journal of biological chemistry 2002
Sources and properties of triglyceride-rich lipoproteins containing apoB-48 and apoB-100 in postprandial blood plasma of patients with primary combined hyperlipidemia
J Kovar, RJ Havel
Journal of lipid research 2002
Trafficking of Cholesterol from Cell Bodies to Distal Axons in Niemann Pick C1-deficient Neurons
B Karten, DE Vance, RB Campenot, JE Vance
The Journal of biological chemistry 2002
Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy.
Holtzman DM
Journal of molecular neuroscience : MN 2001
Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice
RB DeMattos, RP Brendza, JE Heuser, M Kierson, JR Cirrito, J Fryer, PM Sullivan, AM Fagan, X Han, DM Holtzman
Neurochemistry International 2001
Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice
A Auger, TQ Truong, D Rhainds, J Lapointe, F Letarte, L Brissette
European Journal of Biochemistry 2001
Expression of the Apolipoprotein E Gene in the Skin is Controlled by a Unique Downstream Enhancer
S Grehan, C Allan, E Tse, D Walker, JM Taylor
Journal of Investigative Dermatology 2001
Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2
F Brahimi, P Bertrand, M Starck, MM Galteau, G Siest
Cell Biochemistry and Function 2001
Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments
J Levin-Allerhand, BS McEwen, CE Lominska, DB Lubahn, KS Korach, JD Smith
Journal of Neurochemistry 2001
Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response
JR Lynch, D Morgan, J Mance, WD Matthew, DT Laskowitz
Journal of Neuroimmunology 2001
Downregulation of Microglial Activation by Apolipoprotein E and ApoE-Mimetic Peptides
DT Laskowitz, AD Thekdi, SD Thekdi, SK Han, JK Myers, SV Pizzo, ER Bennett
Experimental Neurology 2001
Brain Injury
RS Clark, P Kochanek
Brain Injury 2001
Characterization of four lipoprotein classes in human cerebrospinal fluid
S Koch, N Donarski, K Goetze, M Kreckel, HJ Stuerenburg, C Buhmann, U Beisiegel
Journal of lipid research 2001
Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-? deposition in vivo
AM Fagan, DM Holtzman
Microscopy Research and Technique 2000
Lipoproteins in the Central Nervous System
MJ Ladu, C Reardon, LV Eldik, AM Fagan, G Bu, D Holtzman, GS Getz
Annals of the New York Academy of Sciences 2000
Intraventricular Infusion of Apolipoprotein E Ameliorates Acute Neuronal Damage After Global Cerebral Ischemia in Mice
K Horsburgh, J McCulloch, M Nilsen, E McCracken, C Large, AD Roses, JA Nicoll
Journal of Cerebral Blood Flow and Metabolism 2000
Differences in the A?40/A?42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype
AM Fagan, LH Younkin, JC Morris, JD Fryer, TG Cole, SG Younkin, DM Holtzman
Annals of Neurology 2000
The role of apolipoprotein E in Alzheimer’s disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models
K Horsburgh, MO McCarron, F White, JA Nicoll
Neurobiology of Aging 2000
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection
A M Saunders, M K Trowers, R A Shimkets, S Blakemore, D J Crowther, T A Mansfield, D M Wallace, W J Strittmatter, A D Roses
Biochimica et Biophysica Acta 2000
Apolipoprotein E and Alzheimer Disease: An Update on Genetic and Functional Analyses
AM Saunders
Journal of Neuropathology and Experimental Neurology 2000
Duplicated Downstream Enhancers Control Expression of the Human Apolipoprotein E Gene in Macrophages and Adipose Tissue
SJ Shih, C Allan, S Grehan, E Tse, C Moran, JM Taylor
The Journal of biological chemistry 2000
Effect of Macrophage-Derived Apolipoprotein E on Established Atherosclerosis in Apolipoprotein E–Deficient Mice
W Shi, X Wang, NJ Wang, WH McBride, AJ Lusis
Arteriosclerosis, thrombosis, and vascular biology 2000
Low- and High-Density Lipoprotein Metabolism in HepG2 Cells Expressing Various Levels of Apolipoprotein E
D Charpentier, C Tremblay, E Rassart, D Rhainds, A Auger, RW Milne, L Brissette
Biochemistry 2000
Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease
DM Holtzman, KR Bales, S Wu, P Bhat, M Parsadanian, AM Fagan, LK Chang, Y Sun, SM Paul
Journal of Clinical Investigation 1999
Macrophages, lipoprotein metabolism, and atherosclerosis
MR Linton, S Fazio
Current Opinion in Lipidology 1999
Epidermal expression of apolipoprotein E gene during fin and scale development and fin regeneration in zebrafish
MJ Monnot, PJ Babin, G Poleo, M Andre, L Laforest, C Ballagny, MA Akimenko
Developmental Dynamics 1999
Apolipoprotein E and β-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent
U Beffert, JS Cohn, C Petit-Turcotte, M Tremblay, N Aumont, C Ramassamy, J Davignon, J Poirier
Brain Research 1999
Differential Generation of High-Density Lipoprotein by Endogenous and Exogenous Apolipoproteins in Cultured Fetal Rat Astrocytes
J Ito, LY Zhang, M Asai, S Yokoyama
Journal of Neurochemistry 1999
Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies
MR Linton, S Fazio
Current Opinion in Lipidology 1999
Sialylated Human Apolipoprotein E (apoEs) Is Preferentially Associated with Neuron-Enriched Cultures from APOE Transgenic Mice
PT Xu, D Schmechel, HL Qiu, M Herbstreith, T Rothrock-Christian, M Eyster, AD Roses, JR Gilbert
Neurobiology of Disease 1999
Retroviral Gene Therapy in ApoE-Deficient Mice: ApoE Expression in the Artery Wall Reduces Early Foam Cell Lesion Formation
AH Hasty, MR Linton, SJ Brandt, VR Babaev, LA Gleaves, S Fazio
Circulation 1999
Mouse Models in the Study of Genetic Neurological Disorders
B Popko
1999
Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration
M Buttini, M Orth, S Bellosta, H Akeefe, R E Pitas, T Wyss-Coray, L Mucke, R W Mahley
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999
Characterization of Apolipoprotein E-containing Lipoproteins in Cerebrospinal Fluid: Effect of Phenotype on the Distribution of Apolipoprotein E
K Yamauchi, M Tozuka, H Hidaka, E Hidaka, Y Kondo, T Katsuyama
Clinical chemistry 1999
Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice
WA Boisvert, LK Curtiss
Journal of lipid research 1999
Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration
Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW
Journal of Neuroscience 1999
Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma
J Fan, ZS Ji, Y Huang, H Silva, D Sanan, RW Mahley, TL Innerarity, JM Taylor
Journal of Clinical Investigation 1998
Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor
MF Linton, AH Hasty, VR Babaev, S Fazio
Journal of Clinical Investigation 1998
Human apolipoprotein E allele-specific brain expressing transgenic mice
JD Smith, J Sikes, JA Levin
Neurobiology of Aging 1998
Cis-Acting Human ApoE Tissue Expression Element is Associated with Human Pattern of Intraneuronal ApoE in Transgenic Mice
AD Roses, J Gilbert, PT Xu, P Sullivan, B Popko, DS Burkhart, T Christian-Rothrock, AM Saunders, N Maeda, DE Schmechel
Neurobiology of Aging 1998
Apolipoprotein E and ALzheimer's Disease: The Tip of the Susceptibility Iceberg
AD Roses
Annals of the New York Academy of Sciences 1998
Proposal of a multicompartmental model for use in the study of apolipoprotein E metabolism
JS Millar, AH Lichtenstein, GG Dolnikowski, JM Ordovas, EJ Schaefer
Metabolism 1998
Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study
A Slooter
Neuroscience Letters 1998
Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins
D Games, D Adams, R Alessandrini, R Barbour, P Berthelette, C Blackwell, T Carr, J Clemens, T Donaldson, F Gillespie
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998
Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins
D Games, D Adams, R Alessandrini, R Barbour, P Berthelette, C Blackwell, T Carr, J Clemens, T Donaldson, F Gillespie
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998
Liver Transplant Pathology in Pediatric Metabolic Disorders
R Jaffe
Pediatric and Developmental Pathology 1998
Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins
KS Montine, CN Bassett, JJ Ou, WR Markesbery, LL Swift, TJ Montine
Journal of lipid research 1998
Glial Fibrillary Acidic Protein–Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins
Sun Y, Wu S, Bu G, Onifade MK, Patel SN, LaDu MJ, Fagan AM, Holtzman DM
Journal of Neuroscience 1998
ApoE, Alzheimer's Disease, and Recovery from Brain Stress
AD Roses, AM Saunders
Annals of the New York Academy of Sciences 1997
Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
S Fazio, VR Babaev, AB Murray, AH Hasty, KJ Carter, LA Gleaves, JB Atkinson, MF Linton
Proceedings of the National Academy of Sciences 1997
Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease
A Merched, H Blain, S Visvikis, B Herbeth, C Jeandel, G Siest
Journal of the Neurological Sciences 1997
Advances in Molecular and Cell Biology
KJ Clemetson
Advances in Molecular and Cell Biology 1997
Influence of macrophage-derived apoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apoprotein E-deficient mice
J Spangenberg, LK Curtiss
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1997
Two Hepatic Enhancers, HCR.1 and HCR.2, Coordinate the Liver Expression of the Entire Human Apolipoprotein E/C-I/C-IV/C-II Gene Cluster
CM Allan, S Taylor, JM Taylor
The Journal of biological chemistry 1997
Cerebrovascular transport of Alzheimer's amyloidβ and apolipoproteins J and E: Possible anti-amyloidogenic role of the blood-brain barrier
BV Zlokovic
Life Sciences 1996
Human apolipoprotein E: the Alzheimer's disease connection
DM Holtzman, AM Fagan
The FASEB Journal 1996
Murine bone marrow transplantation as a novel approach to studying the role of macrophages in lipoprotein metabolism and atherogenesis
S Fazio, MR Linton
Trends in Cardiovascular Medicine 1996
In Vivo Footprinting Analysis of the Hepatic Control Region of the Human Apolipoprotein E/C-I/C-IV/C-II Gene Locus
Q Dang, J Taylor
The Journal of biological chemistry 1996
Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall
H Shimano, J Ohsuga, M Shimada, Y Namba, T Gotoda, K Harada, M Katsuki, Y Yazaki, N Yamada
Journal of Clinical Investigation 1995
Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation
WA Boisvert, J Spangenberg, LK Curtiss
Journal of Clinical Investigation 1995
Relationship of apolipoproteins Al, B and lipoprotein Lp(a) to hepatic function of liver recipients during the early post-transplant period
VW Armstrong, E Schütz, M Kaltefleiter, M Luy, M Helmhold, E Wieland, B Ringe, M Oellerich
European Journal of Clinical Investigation 1995
Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall
H Shimano, J Ohsuga, M Shimada, Y Namba, T Gotoda, K Harada, M Katsuki, Y Yazaki, N Yamada
Science 1995
Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth
S Bellosta, BP Nathan, M Orth, LM Dong, RW Mahley, RE Pitas
The Journal of biological chemistry 1995
The Human Apolipoprotein E Gene Is Negatively Regulated in Human Liver HepG2 Cells by the Transcription Factor BEF-1
DT Berg, DS Calnek, BW Grinnell
The Journal of biological chemistry 1995
Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease
T Lehtimki, T Pirttil, PD Mehta, HM Wisniewski, H Frey, T Nikkari
Human Genetics 1995
Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels
P Knijff, AM van Maagdenberg, RR Frants, LM Havekes
Human Mutation 1994
Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides*
MC Cabezas, DW Erkelens, LA Kock, TW de Bruin
European Journal of Clinical Investigation 1994
Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)
MF Linton, RV Farese, G Chiesa, DS Grass, P Chin, RE Hammer, HH Hobbs, SG Young
Journal of Clinical Investigation 1993
Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters
JS Cohn, EJ Johnson, JS Millar, SD Cohn, RW Milne, YL Marcel, RM Russell, EJ Schaefer
Journal of lipid research 1993
Localization of a liver-specific enhancer in the apolipoprotein E/C-I/C-II gene locus
NS Shachter, Y Zhu, A Walsh, JL Breslow, JD Smith
Journal of lipid research 1993
A far-downstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice
WS Simonet, N Bucay, SJ Lauer, JM Taylor
The Journal of biological chemistry 1993
Apolipoprotein B gene mutations affecting cholesterol levels
RV Farese, MF Linton, SG Young
Journal of Internal Medicine 1992
Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine
AH Lichtenstein, DL Hachey, JS Millar, JL Jenner, L Booth, J Ordovas, EJ Schaefer
Journal of lipid research 1992
Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a)
G Chiesa, HH Hobbs, ML Koschinsky, RM Lawn, SD Maika, RE Hammer
The Journal of biological chemistry 1992
The amino-terminal hydrophobic region of the small subunit of calcium-activated neutral protease (CANP) is essential for its activation by phosphatidylinositol
S Bellosta, RW Mahley, DA Sanan, J Murata, DL Newland, JM Taylor, RE Pitas
Journal of Clinical Investigation 1986
The amino-terminal hydrophobic region of the small subunit of calcium-activated neutral protease (CANP) is essential for its activation by phosphatidylinositol
S Bellosta, RW Mahley, DA Sanan, J Murata, DL Newland, JM Taylor, RE Pitas
Journal of Clinical Investigation 1986

← Previous 1 2 … 10 11 12 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
147 readers on Mendeley
See more details